HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alan Melcher Selected Research

Alan Melcher Research Topics

Disease

86Neoplasms (Cancer)
04/2024 - 06/2002
25Melanoma (Melanoma, Malignant)
12/2023 - 10/2002
14Vesicular Stomatitis
01/2021 - 10/2002
7Infections
01/2024 - 10/2012
6Experimental Melanoma
04/2016 - 03/2005
5Virus Diseases (Viral Diseases)
01/2024 - 10/2012
5Prostatic Neoplasms (Prostate Cancer)
11/2022 - 12/2007
5Brain Neoplasms (Brain Tumor)
01/2022 - 04/2016
4Glioma (Gliomas)
01/2022 - 02/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
03/2024 - 08/2013
3Bites and Stings (Sting)
01/2024 - 01/2020
3Carcinoma (Carcinomatosis)
07/2021 - 03/2007
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 08/2007
2Squamous Cell Carcinoma of Head and Neck
04/2024 - 01/2021
2Breast Neoplasms (Breast Cancer)
04/2024 - 10/2022
2Inflammation (Inflammations)
01/2024 - 11/2022
2Rectal Neoplasms (Rectal Cancer)
01/2021 - 08/2009
2Neoplasm Metastasis (Metastasis)
01/2018 - 01/2008
2Liver Neoplasms (Liver Cancer)
01/2018 - 08/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 02/2015
1Necrosis
04/2024
1Fistula
04/2024
1Fatigue
04/2024
1Deglutition Disorders (Dysphagia)
04/2024
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2024
1Triple Negative Breast Neoplasms
10/2022
1Ovarian Epithelial Carcinoma
07/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2021
1Cytokine Release Syndrome
12/2020

Drug/Important Bio-Agent (IBA)

25AntigensIBA
01/2023 - 10/2002
9Proteins (Proteins, Gene)FDA Link
01/2023 - 03/2007
9Immune Checkpoint InhibitorsIBA
01/2022 - 01/2018
9Neoplasm Antigens (Tumor Antigens)IBA
01/2019 - 10/2002
8CytokinesIBA
01/2020 - 09/2007
6VaccinesIBA
01/2020 - 10/2002
5Antiviral Agents (Antivirals)IBA
01/2021 - 11/2008
4DNA (Deoxyribonucleic Acid)IBA
01/2024 - 09/2004
4InterferonsIBA
01/2024 - 02/2011
4talimogene laherparepvecIBA
12/2023 - 08/2013
4Complementary DNA (cDNA)IBA
01/2016 - 11/2011
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2024 - 11/2022
3Neutralizing AntibodiesIBA
01/2021 - 01/2008
3EpitopesIBA
01/2020 - 02/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 05/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2011 - 01/2008
3CD40 Ligand (CD40L)IBA
04/2010 - 09/2006
3Interleukin-2 (IL2)IBA
01/2009 - 07/2008
3Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2006 - 10/2002
2RNA (Ribonucleic Acid)IBA
03/2024 - 01/2021
2ChemokinesIBA
11/2022 - 02/2011
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022 - 10/2014
2Interferon Type IIBA
03/2021 - 04/2010
2Interleukin-6 (Interleukin 6)IBA
12/2020 - 11/2017
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
06/2018 - 01/2018
2PLX 4720IBA
05/2015 - 05/2015
2Conditioned Culture MediaIBA
02/2015 - 02/2011
2Ganciclovir (Cytovene)FDA LinkGeneric
02/2015 - 09/2006
2Interferon LambdaIBA
01/2013 - 06/2010
2Therapeutic UsesIBA
10/2011 - 01/2011
2Docetaxel (Taxotere)FDA Link
06/2011 - 11/2010
2Cancer VaccinesIBA
03/2010 - 09/2003
2AutoantigensIBA
12/2007 - 03/2005
2Glycoproteins (Glycoprotein)IBA
02/2006 - 10/2002
1Epinephrine (Adrenaline)FDA LinkGeneric
04/2024
1Antineoplastic Agents (Antineoplastics)IBA
04/2024
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2024
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2024
1Interferon Regulatory FactorsIBA
01/2024
1Viral DNAIBA
01/2024
1Pattern Recognition ReceptorsIBA
01/2024
1Nucleic AcidsIBA
01/2024
1ClaudinsIBA
11/2022
1AndrogensIBA
11/2022
1sargramostim (Leukine)FDA Link
01/2022
1Adenosine (Adenocard)FDA LinkGeneric
03/2021
1Programmed Cell Death 1 ReceptorIBA
03/2021
1Member 14 Tumor Necrosis Factor ReceptorsIBA
03/2021
1LigandsIBA
03/2021
1Interferon-betaIBA
01/2021
1CytosineIBA
01/2021
1APOBEC-1 DeaminaseIBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1MutagensIBA
01/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2021
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
01/2021
1Viral RNAIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020

Therapy/Procedure

48Therapeutics
04/2024 - 10/2002
31Immunotherapy
04/2024 - 06/2002
17Oncolytic Virotherapy
01/2022 - 01/2008
14Drug Therapy (Chemotherapy)
07/2021 - 08/2007
9Radiotherapy
04/2024 - 08/2009
4Neoadjuvant Therapy
04/2024 - 01/2016
4Biological Therapy
06/2018 - 07/2008
3Injections
04/2024 - 09/2006
2Chemoradiotherapy
01/2023 - 08/2009
2Intradermal Injections
09/2006 - 09/2004